Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Pro-Asp)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST002247 AN003670 Microbiota and Health Study (Dhaka, Bangladesh) Feces Human Broad Institute of MIT and Harvard Abundances
ST001074 AN001756 Open source discovery of starting points for next generation chemoprotective antimalarial drugs (Biofocus 1) Parasite Human Pennsylvania State University Average Peak Area
ST002747 AN004455 Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections Cultured cells Human CZ Biohub counts, height
ST002747 AN004455 Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections Cultured cells Rickettsia parkeri CZ Biohub counts, height
ST001188 AN001980 P. falciparum infected erythrocytes Cultured cells Plasmodium falciparum Malaria University of Melbourne ion count
ST000441 AN000692 Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways Plasmodium cells Plasmodium falciparum Malaria Pennsylvania State University log2 fold change vs untreated
ST001324 AN002202 Metabolomics Adaptation of Juvenile Pacific Abalone Haliotis discus hannai to Heat Stress Pacific Abalone Institute of Oceanology, Chinese Academy of Sciences mV*min
ST001660 AN002711 Plasmodium falciparum metabolomics as a result of treatment with putative acetyl-CoA synthetase inhibitors Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Normalized and blank subtracted peak area
ST002009 AN003275 Metabolomics analysis of stress erythroid progenitors Stem cells Mouse Inflammation Pennsylvania State University Normalized peak area
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Blood Human Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Blood Plasmodium falciparum Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Cultured cells Human Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST002024 AN003294 Plasmodium falciparum stable-isotope carbon labeling to explore metabolic consequences of keto–acid dehydrogenase disruption Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST002011 AN003277 The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. Blood Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002011 AN003278 The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. Blood Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002011 AN003279 The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. Blood Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002078 AN003387 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002078 AN003388 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002078 AN003389 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002078 AN003390 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University peak area
ST001232 AN002050 Combining stage - specificity and metabolomic profiling to advance drug discovery for malaria Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Peak area
ST001279 AN002120 K13 mutations driving artemisinin resistance rewrite Plasmodium falciparum’s programmed intra-erythrocytic development and transform mitochondrial physiology Parasite Plasmodium falciparum Malaria Penn State Peak area
ST002505 AN004126 A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) Cultured cells Human Cancer University of Science and Technology of China Peak area
ST001149 AN001896 Plasmodium Niemann-Pick Type C1-Related Protein is a Druggable Target Required for Parasite Membrane Homeostasis Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Peak Area Post-Blank Subtraction
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides fragilis Stanford University Peak height
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides thetaiotaomicron Stanford University Peak height
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides uniformis Stanford University Peak height
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Blautia producta Stanford University Peak height
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium clostridioforme Stanford University Peak height
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium hathewayi Stanford University Peak height
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium hylemonae Stanford University Peak height
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium scindens Stanford University Peak height
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium symbiosum Stanford University Peak height
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus faecalis Stanford University Peak height
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus faecium Stanford University Peak height
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus hirae Stanford University Peak height
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Escherichia fergusonii Stanford University Peak height
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Flavonifractor plautii Stanford University Peak height
ST002832 AN004625 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Parabacteroides distasonis Stanford University Peak height
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides fragilis Stanford University Peak height
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides thetaiotaomicron Stanford University Peak height
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Bacteroides uniformis Stanford University Peak height
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Blautia producta Stanford University Peak height
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium clostridioforme Stanford University Peak height
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium hathewayi Stanford University Peak height
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium hylemonae Stanford University Peak height
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium scindens Stanford University Peak height
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Clostridium symbiosum Stanford University Peak height
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus faecalis Stanford University Peak height
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus faecium Stanford University Peak height
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Enterococcus hirae Stanford University Peak height
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Escherichia fergusonii Stanford University Peak height
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Flavonifractor plautii Stanford University Peak height
ST002832 AN004626 Resource competition predicts assembly of in vitro gut bacterial communities- HILIC Bacterial cells Parabacteroides distasonis Stanford University Peak height
ST002407 AN003924 Spatial, temporal, and inter-subject variation of the metabolome along the human upper intestinal tract Intestine Human UC Davis Peak Height
ST001794 AN002912 Metabolomics Analysis of Time-Series Gastrointestinal Lumen Samples Intestine Human University of California, Davis Peak Height Intensity
ST000046 AN000078 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST002512 AN004137 Gnotobiotic mice: Metabolites in intestinal contents of germ-free mice colonized with strains of gut bacterium Eggerthella lenta Intestine Mouse University of California, San Francisco relative ion counts
  logo